| Revenue growth | 9% YoY in Q4; FY26 flat overall. |
|---|---|
| Margins | Resilient; Q4 EBITDA margin 32.2%, Gross Margin 69.6%. |
| Demand visibility | Steady category volume growth with urban recovery. |
| Management confidence | Strong foundation for consistent long-term growth. |
Growth
Q4'FY26: Revenue ₹1,583 Cr (+9% YoY), PAT ₹353 Cr (+9.2% YoY). FY26: Revenue flat YoY, PAT -1.8%.
Outlook
Focus on H2'26 recovery momentum (+5.2% growth) and accelerating premiumization (Visible White, Colgate Total).
Risks
Rural brushing frequency remains low (50% not daily); competitive pressures in core segments.
Earnings Call filed with BSE, NSE: COLPAL. Summary written with AI assistance from the document.
Colgate-Palmolive (India) Ltd: key numbers
- Share price
- ₹1,809.40
- Market cap
- ₹49,213 Cr
- Revenue (annual)
- ₹6,035 Cr
- Net profit (annual)
- ₹1,325 Cr
- P/E (TTM)
- 36.5×Sector 42.5×
- Promoter holding
- 51.00%+0.00% QoQ
- FII holding
- 13.60%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Colgate-Palmolive (India) Ltd
All →Colgate-Palmolive (India) Business Update
Colgate-Palmolive (India) has partnered with Kaun Banega Crorepati Season 18 to integrate oral health awareness messages into the show's daily narrative through unique celebrity sign-offs.
Colgate-Palmolive (India) Management Change
Colgate-Palmolive (India) Limited announced the resignation of Mr. G. Ramprasad as its Internal Auditor, effective August 31, 2026, to explore other opportunities.
Colgate-Palmolive (India) Earnings Call Transcript: Key Takeaways
Colgate-Palmolive (India) reported Q1 sales of Rs. 1591 crores, a 12% increase. Strategy focuses on driving oral care consumption and premiumisation, with premium segments growing 5X faster than competitors.
Colgate-Palmolive (India) Management Change
Colgate-Palmolive (India) announced the resignation of MD & CEO Prabha Narasimhan, effective September 27, 2026. Manish Anandani succeeds her as MD & CEO effective September 28, 2026.
Colgate-Palmolive (India) Business Update
Colgate-Palmolive's PerioGard portfolio became India's first gum care regimen to earn the Indian Society of Periodontology's (ISP) Seal of Acceptance for its clinical standards.
Colgate-Palmolive (India) Investor Presentation: Key Takeaways
Colgate India reported robust Q1 FY27 net sales growth of 12% YoY, accelerating from 9% in the previous quarter. The company is focused on category growth through premiumization and expanding rural toothbrush penetration.